Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies
about
Endoglin expression in metastatic breast cancer cells enhances their invasive phenotypeRelease of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecinHighlights on endoglin (CD105): from basic findings towards clinical applications in human cancerEndoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vesselsThe type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells.Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studies.Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood.The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort.A multi-gene transcriptional profiling approach to the discovery of cell signature markersLumican reduces tumor growth via induction of fas-mediated endothelial cell apoptosis.Angiogenesis in the progression of cutaneous squamous cell carcinoma: an immunohistochemical study of endothelial markers.Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?Positron emission tomography imaging of CD105 expression during tumor angiogenesis.In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesisAbnormalities in pericytes on blood vessels and endothelial sprouts in tumorsToward angiogenesis of implanted bio-artificial liver using scaffolds with type I collagen and adipose tissue-derived stem cellsMicroarray analysis of B-cell lymphoma cell lines with the t(14;18)Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers.CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells.Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants.A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a smaCancer prevention and therapy through the modulation of the tumor microenvironment.Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.TGF-β and its coreceptors in cancerogenesis: an overview.Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma.Endoglin for tumor imaging and targeted cancer therapy.Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model.Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma.Identification of endoglin-dependent BMP-2-induced genes in the murine periodontal ligament cell line PDL-L2.(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.The role of endoglin in post-ischemic revascularization.The effect of amniotic membrane extract on umbilical cord blood mesenchymal stem cell expansion: is there any need to save the amniotic membrane besides the umbilical cord blood?Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.Characterization of murine S-endoglin isoform and its effects on tumor development.TGFbeta1 expression in colonic mucosa: modulation by dietary lipids.
P2860
Q24307831-4CDCCA86-F8F0-4AD1-AA92-0202566CD042Q24795283-D6B8F5E6-A147-49F5-8CA3-8404589309CAQ24798737-4C5F5A48-7541-432B-9250-125F113860A7Q28207513-10A904AE-5FC4-4D21-A211-2E090E83D038Q30582833-F20BF429-616B-47B6-A37D-FB3C7D5B97E5Q33187344-73CAC3C3-7118-437A-B9B1-73AB60455B54Q33241639-0D6B07AF-76D2-4386-93D4-AB43A3EC0FDDQ33338664-6172FA66-7A12-4C2C-B169-E1BDAA2EA949Q33916338-C73187DC-5248-4955-8EFC-47255461E87AQ34239837-3FFE63BF-42B4-43C5-8A4D-DFFC1BBC4D1BQ34491236-557FE95D-5E8E-49E3-98E1-4CF0BE6C6349Q34619029-7E6D2F97-CB1D-4448-BA26-918A87DAAD1AQ34768754-BD5200BC-1DF5-40EC-9B45-6AFA022BF8DFQ34811268-30133658-4434-45F8-9472-F77DAF9CE907Q35017120-915B7965-CEB5-43A8-8DD3-E4F889552B90Q35291271-F6132FB4-B66D-4A7D-AA9B-38A59B3163D2Q35788785-E8FBE9C9-F953-48A8-B6FB-C267CB2CFD57Q35826262-D13291F3-DA0A-4CBB-A0FF-D53285DF1F28Q35869395-DC409B6C-CF88-4674-AA46-00AA02C0470AQ36285676-F8F4B6F4-8AAE-4C23-94C5-5C9EDABF8127Q36320615-00BB20F6-A137-4472-AB30-561CF6F004DCQ36694709-1F37545F-865C-4AD2-A245-B8EB1C6C900CQ36756322-2D7AC507-77FB-4594-8D9D-B5C4D4C7B1CDQ36984261-D15669E8-A945-4612-B893-5CF490BA5E4EQ37058267-8E1099FB-8B0C-4A8F-AD9D-F556E0494B0FQ37228130-4EDC6704-7325-46C3-B840-6B1E9BDB8218Q37340349-12473850-6AED-46EF-804B-1DE61ED3F01FQ37610628-67870466-6973-43BA-BC2B-41B8A8D5A177Q37959017-1FF5AB8B-0DC0-4E3B-9913-C61A663A20E2Q38002119-163557B7-306C-4846-8B2A-962922BE71E2Q38074721-5F428942-FCFF-49F2-86DC-9CCF3D2717ABQ38245841-154EC45F-F612-4998-A541-4BC1EB4EA529Q38962280-099664B3-AA61-489E-92A4-75F5D85444DDQ38982711-BDD6A542-0F22-48D9-9DFB-662259FCC9FAQ39023017-153279A9-7CEC-4344-94AC-F8ECF5805E6DQ39036151-5B914631-5326-43DD-AE02-F6D416731082Q39939439-785777FA-9F31-4F0C-9CE9-6C5E79664437Q40251249-72DAAE02-B991-4ACF-B914-C772018695ACQ40439634-1466CCEE-F230-4503-AAAE-FAC7FC4EECAAQ40622411-57929365-1A0D-4C44-84AA-B80B89BA5649
P2860
Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Endoglin: An accessory compone ...... otential in human malignancies
@ast
Endoglin: An accessory compone ...... otential in human malignancies
@en
Endoglin: An accessory compone ...... otential in human malignancies
@en-gb
Endoglin: An accessory compone ...... otential in human malignancies
@nl
type
label
Endoglin: An accessory compone ...... otential in human malignancies
@ast
Endoglin: An accessory compone ...... otential in human malignancies
@en
Endoglin: An accessory compone ...... otential in human malignancies
@en-gb
Endoglin: An accessory compone ...... otential in human malignancies
@nl
prefLabel
Endoglin: An accessory compone ...... otential in human malignancies
@ast
Endoglin: An accessory compone ...... otential in human malignancies
@en
Endoglin: An accessory compone ...... otential in human malignancies
@en-gb
Endoglin: An accessory compone ...... otential in human malignancies
@nl
P2093
P2860
P921
P356
P1476
Endoglin: An accessory compone ...... otential in human malignancies
@en
P2093
E Fonsatti
L Del Vecchio
L Sigalotti
M Altomonte
M R Nicotra
P G Natali
P2860
P356
10.1002/JCP.1095
P407
P577
2001-07-01T00:00:00Z